Carotid endarterectomy for symptomatic carotid stenosis

Kittipan Rerkasem1, Peter M Rothwell

  • 1Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, 50200.

Insights

Carotid endarterectomy benefits patients with 50-99% stenosis, especially those with severe narrowing. Surgery is not recommended for near-occlusions or less than 30% stenosis.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Evidence-Based Medicine

Background:

  • Severe carotid artery stenosis is a significant risk factor for stroke.
  • Carotid endarterectomy is a surgical option to reduce stroke risk, but carries potential complications.

Purpose of the Study:

  • To compare the benefits and risks of carotid endarterectomy plus medical management versus medical management alone.
  • To evaluate outcomes in patients with recent symptomatic carotid stenosis (transient ischaemic attack or non-disabling stroke).

Main Methods:

  • Systematic review and pooled analysis of individual patient data from three randomized controlled trials.
  • Inclusion of 6092 patients with 35,000 patient-years of follow-up.
  • Reassessment of carotid angiograms and outcomes to ensure comparability.

Main Results:

  • Carotid endarterectomy showed significant benefit for stenosis between 70%-99% (16.0% ARR) and marginal benefit for 50%-69% stenosis (4.6% ARR).
  • No significant benefit was observed for stenosis <30% or near-occlusions.
  • Surgical benefit was greatest in men, older patients (≥75 years), and those operated on within two weeks of symptom onset.

Conclusions:

  • Carotid endarterectomy is beneficial for symptomatic stenosis of 50%-99%, particularly higher grades, in surgically-fit patients with low complication rates.
  • The timing of surgery after symptom onset influences benefit.
  • Long-term benefit for near-occlusions remains uncertain.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...